Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
COEPW
COEPW | US
0.01
USD0.00
24.24%
COEPW | US
Loading StockChartView...
About COEPW
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
0.01
Open
0.01
High
0.01
Low
0.01
Coeptis Therapeutics Holdings Inc. a biopharmaceutical company develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK a cell therapy for the treatment of CD38-related cancers including multiple myeloma chronic lymphocytic leukemia and acute myeloid leukemia; SNAP-CAR a CAR T cell therapy platform co-administered with tagged tumor-specific antibodies to potentially target different tumor types including hematological malignancies and solid tumors; and CD38-Diagnostic an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings Inc. is headquartered in Wexford Pennsylvania.
View LessCOEPW | US
Risk
260.4
Sharpe
-0.19
Luna's Score
48/100
Recommendation
Hold
Luna says (COEPW | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Asset (< 0.2)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
329.5%1 month
260.4%3 months
160.0%6 months
214.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
0.25
Debt to assets
0.15
Ent. to EBITDA
-
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-23.93M
MarketCap
-
MarketCap(USD)
-
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-1.45K
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.00
Range1M
0.00
Range3M
0.01
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
4.87
Price X volume
1.31K
